UCB, Novo Nordisk, Sanofi and MSD Merck win big at the eyeforpharma Barcelona Awards 2016.
The 2016 eyeforpharma Barcelona Awards saw 18 of pharma’s top 20 compete across five categories with a huge range of patient and customer-centric innovations.
UCB, Novo Nordisk, Sanofi and MSD Merck win big at the eyeforpharma Barcelona Awards 2016.
The 2016 eyeforpharma Barcelona Awards saw 18 of pharma’s top 20 compete across five categories with a huge range of patient and customer-centric innovations.
UCB won big, with two awards collected for the second time running, speaking to their industry leadership in customer-centricity.
They showed impressive resourcefulness to bring together a group containing Epilepsy Scotland, NHS Dumfries & Galloway, GlaxoSmithKline and Eisai Ltd to win the Pharma Collaboration Award with their initiative to transform standards of Epilepsy care; their new training protocol has been recommended for national adoption by the Ministry of Health.
UCB’s Marianne Fraiture also won for contributions to Epilepsy care, with her leadership in adopting Hackathon strategies to design new supportive services winning the Customer Innovator Award. With Hackathon participants from patients, family members, caregivers and the digital community, Fraiture is project managing 5 stand-out teams to prototype their innovations into new services.
Another tech-inspired standout was MSD France’s audacious project ‘Comuniti’, a new social network for the healthcare community, that won the Most Valuable HCP Initiative or Service Award. The program launched with great traction, 65,000 users signed up in just 6-months, testifying to pharma’s ability to compete with more agile industries in launching untested projects.
MSD also joined UCB as a double-winner, by capturing the Most Valued Company Award. The award, which was the only one chosen outside of the eyeforpharma Barcelona judging panel, was determined by a European panel of HCPs asked to nominate the biggest contributor beyond-the-pill.
Sanofi’s Moski Kit, the malaria prevention and treatment awareness game that won the Most Valuable Patient Initiative or Service Award, was another case study in flawless execution. Sanofi invested in a comprehensive participatory design process across four countries before scaling out to deploy over 1,500 kits in schools in 15 Sub-Saharan Countries.
Finally, Novo Nordisk’s Søren Eik Skovlund, Global Senior Manager within Global Access was recognized for his tireless work to transform care delivery within diabetes with the Lifetime Achievement Award. For over a decade, Skovlund has led Novo Nordisk’s Dawntm and Dawn2tm programs, achieving change at a national level within Italy, Denmark, Algeria, China and the US. Skovlund championed progressive project design strategies, such as participatory design, to unite stakeholders around a common objective, understanding and supporting the patient.
The awards reflect eyeforpharma’s mission to evangelize the need for pharma to change its focus from selling products, to seeing the powerful opportunity that pharma has to impact and improve the lives of patients. The winning projects were selected from hundreds of initiatives submitted from teams across the global, and determined by a judging panel of senior industry experts, and patient advocates.
For more information, contact: Emma Goldman, Awards Director egoldman@eyeforpharma.com +44 (0) 207 375 4312